La Jolla Pharmaceutical Stock Net Income
| LJPCDelisted Stock | USD 6.22 0.00 0.00% |
La Jolla Pharmaceutical fundamentals help investors to digest information that contributes to La Jolla's financial success or failures. It also enables traders to predict the movement of LJPC Stock. The fundamental analysis module provides a way to measure La Jolla's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to La Jolla stock.
LJPC |
La Jolla Pharmaceutical Company Net Income Analysis
La Jolla's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current La Jolla Net Income | 5.24 M |
Most of La Jolla's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, La Jolla Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, La Jolla Pharmaceutical reported net income of 5.24 M. This is 98.46% lower than that of the Healthcare sector and 92.52% lower than that of the Biotechnology industry. The net income for all United States stocks is 99.08% higher than that of the company.
LJPC Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses La Jolla's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of La Jolla could also be used in its relative valuation, which is a method of valuing La Jolla by comparing valuation metrics of similar companies.La Jolla is currently under evaluation in net income category among related companies.
LJPC Fundamentals
| Return On Equity | 0.0544 | |||
| Return On Asset | 1.64 | |||
| Profit Margin | 10.08 % | |||
| Operating Margin | 4.68 % | |||
| Current Valuation | 242.85 M | |||
| Shares Outstanding | 27.52 M | |||
| Shares Owned By Insiders | 1.91 % | |||
| Shares Owned By Institutions | 71.79 % | |||
| Number Of Shares Shorted | 202.51 K | |||
| Price To Earning | 38.88 X | |||
| Price To Book | 30.11 X | |||
| Price To Sales | 3.29 X | |||
| Revenue | 52.01 M | |||
| Gross Profit | 63.08 M | |||
| EBITDA | 4.09 M | |||
| Net Income | 5.24 M | |||
| Cash And Equivalents | 44.56 M | |||
| Cash Per Share | 1.74 X | |||
| Total Debt | 124.8 M | |||
| Debt To Equity | 7.16 % | |||
| Current Ratio | 3.92 X | |||
| Book Value Per Share | (3.36) X | |||
| Cash Flow From Operations | 13.59 M | |||
| Short Ratio | 0.46 X | |||
| Earnings Per Share | (1.44) X | |||
| Price To Earnings To Growth | 11.72 X | |||
| Number Of Employees | 61 | |||
| Beta | 1.97 | |||
| Market Capitalization | 171.2 M | |||
| Total Asset | 89.52 M | |||
| Retained Earnings | (1.06 B) | |||
| Working Capital | 79.5 M | |||
| Current Asset | 86.74 M | |||
| Current Liabilities | 7.24 M | |||
| Z Score | -14.8 |
About La Jolla Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze La Jolla Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of La Jolla using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of La Jolla Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in LJPC Stock
If you are still planning to invest in La Jolla Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the La Jolla's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |